In this blog for patients and doctors, Dr Mark Horowitz, training psychiatrist and Clinical Research Fellow at University College London, looks at the latest Cochrane evidence on how to safely stop antidepressants and explores the implications for patients and doctors having to navigate this area so neglected by medical researchers. Mark’s personal experience of the difficulty in coming off antidepressants led to an interest in the little-understood field of stopping psychiatric medication, and the balance of harms and benefits.
Mark Horowitzhas published 1 posts
Dr Mark Horowitz (BA, BSc, MA, GDPsych, MBBS (Hons), PhD) is a Clinical Research Fellow in Psychiatry at University College London. He is a trainee psychiatrist and has completed a PhD in the neurobiology of antidepressants and depression at the Institute of Psychiatry at King’s College London. His personal experience of the difficulty in coming off antidepressants led to an interest in the little understood field of de-prescribing in psychiatry, and the balance of harms and benefits of psychiatric medication. He has published papers on this topic in The Lancet Psychiatry, JAMA Psychiatry and other scientific journals. He authored the Royal College of Psychiatry guidance on ‘Stopping antidepressants.” He is Associate Editor of Therapeutic Advances in Psychopharmacology and is guest editing a special edition of this journal on ‘Discontinuing psychotropic medications.’ Twitter handle: @markhoro Website: markhorowitz.org